All news from Ophthalmology

neurodegenerative disorder

Technology Effectively Measures Disease Severity In Rare Neuro degenerative Disorder

A rapid, non-invasive eye exam that uses innovative imaging technology effectively measures the severity of disease in patients with a rare neurodegenerative disease called Friedrich ataxia, according to a study by Weill Cornell Medicine, Weill Cornell Medicine-Qatar and NewYork-Presbyterian researchers. because  The results suggest that the exam, known as corneal confocal microscopy (CCM), therefore it…

sight problems

Sight Problems Could Benefit From New Surgical Trial

People with sight problems could benefit from a surgical trial advance that has been shown to help restore the surface of the eye. Doctors made the world-first step by carrying out a clinical trial using stem cells; from donors to create tissue that is transplanting into patients with a condition that causes blindness. Researchers say…

Eyeglasses

Americans Used Less Eye Care In 2014 versus 2008

Americans were less likely to use eye care in 2014 versus 2008 but had decreased difficulty affording eyeglasses from 2014 onward; according to a study published online in JAMA Ophthalmology. Eye care, including medical, surgical and optical care. In the US, this requires four years of college, four years of medical school, one-year general internship; three…

Diabetic Retinopathy

GLP-1 Receptor Agonists No Risk For Diabetic Retinopathy

Glucagon-like peptide 1 receptor agonists (GLP-1RAs) do not appear to increase patients’ risk for diabetic retinopathy. According to an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System database. “Physicians do not need to avoid GLP1RA based on concerns of retinopathy,” Dr. Tiansheng Wang from the University of North Carolina at Chapel…

Progressive Cone And Cone-Rod Dystrophies

Progressive cone and cone-rod dystrophies are a clinically and genetically heterogeneous group of inherited retinal diseases characterised by cone photoreceptor degeneration, which may be followed by subsequent rod photoreceptor loss. These disorders typically present with progressive loss of central vision, colour vision disturbance and photophobia. 

New Genetic Mutations Causing Inherited Deaf Blindness

A team of scientists from Sechenov First Moscow State Medical University (MSMU) together with their colleagues described a number of genetic mutations causing Usher syndrome (inherited deaf-blindness) A team of scientists from Sechenov First Moscow State Medical University (MSMU) together with their colleagues from leading scientific centers of Moscow and India described a number of genetic mutations causing Usher syndrome (inherited deaf-blindness).

New Genes Linked To Development Of Age-Related Macular Degeneration

Fight for Sight funded research published this week in  Clinical Epigenetics , has identified new genes linked to the development of  age-related macular degeneration , the leading cause of blindness in the UK. The research team, led by Dr. Louise Porter at the University of Liverpool, has identified genes that may represent new targets for the development of treatments. Currently, there is no available treatment for 85% of people with the common 'dry' form of the disease.

Lipid Impact In The Mechanism Of Dry Eye Disease

Jianzhong Chen, Ph.D., assistant professor at the University of Alabama at Birmingham School of Optometry, along with co-author Kelly Nichols, O.D., MPH, Ph.D., FAAO, dean of the School of Optometry, has published a sensitive method facilitating dry eye disease studies in the Journal of Lipid Research. LR is the most cited lipid journal in the world and is published by The American Society for Biochemistry and Molecular Biology.

New Therapeutic Target For Retinal Vein Occlusion

A clot in the retinal can lead to severe and irreversible loss of vision. In a report in the  American Journal of Pathology investigators used a newly developed model of central retinal vein occlusion (CRVO) in mice that mimics many of the clinical features of CRVO in humans to study the pathologic effects of retinal occlusion and demonstrate the retinoprotective effects of the peptide adrenomedullin (ADM) and its receptor activity-modifying protein RAMP2.